BioMarin Pharmaceutical Inc. (BMRN)
USD 60.58
(-10.23%)
USD 60.58
(-10.23%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.84 Billion USD | 7.32% |
| 2022 | 6.37 Billion USD | 6.19% |
| 2021 | 6 Billion USD | 2.66% |
| 2020 | 5.84 Billion USD | 24.69% |
| 2019 | 4.69 Billion USD | 5.94% |
| 2018 | 4.42 Billion USD | -4.45% |
| 2017 | 4.63 Billion USD | 15.15% |
| 2016 | 4.02 Billion USD | 7.89% |
| 2015 | 3.72 Billion USD | 49.75% |
| 2014 | 2.49 Billion USD | 10.73% |
| 2013 | 2.24 Billion USD | 40.43% |
| 2012 | 1.6 Billion USD | 22.86% |
| 2011 | 1.3 Billion USD | 3.25% |
| 2010 | 1.26 Billion USD | 37.67% |
| 2009 | 917.16 Million USD | 1.15% |
| 2008 | 906.69 Million USD | 11.21% |
| 2007 | 815.27 Million USD | 75.92% |
| 2006 | 463.43 Million USD | 137.29% |
| 2005 | 195.3 Million USD | -16.17% |
| 2004 | 232.96 Million USD | -9.12% |
| 2003 | 256.34 Million USD | 131.74% |
| 2002 | 110.61 Million USD | -35.62% |
| 2001 | 171.81 Million USD | 123.33% |
| 2000 | 76.93 Million USD | -25.7% |
| 1999 | 103.54 Million USD | 228.73% |
| 1998 | 31.5 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.87 Billion USD | 0.45% |
| 2024 Q3 | 6851.19 Billion USD | -3.06% |
| 2024 Q2 | 7.06 Billion USD | 2.83% |
| 2023 Q4 | 6.84 Billion USD | 1.23% |
| 2023 Q3 | 6.75 Billion USD | 2.97% |
| 2023 FY | 6.84 Billion USD | 7.32% |
| 2023 Q2 | 6.56 Billion USD | 2.01% |
| 2023 Q1 | 6.43 Billion USD | 0.92% |
| 2022 Q4 | 6.37 Billion USD | 1.77% |
| 2022 Q1 | 6.06 Billion USD | 0.99% |
| 2022 Q3 | 6.26 Billion USD | 1.92% |
| 2022 Q2 | 6.14 Billion USD | 1.37% |
| 2022 FY | 6.37 Billion USD | 6.19% |
| 2021 Q2 | 5.89 Billion USD | 1.61% |
| 2021 Q1 | 5.8 Billion USD | -0.73% |
| 2021 Q4 | 6 Billion USD | 0.43% |
| 2021 FY | 6 Billion USD | 2.66% |
| 2021 Q3 | 5.97 Billion USD | 1.34% |
| 2020 Q2 | 5.3 Billion USD | 12.27% |
| 2020 Q1 | 4.72 Billion USD | 0.7% |
| 2020 Q3 | 6.15 Billion USD | 16.14% |
| 2020 FY | 5.84 Billion USD | 24.69% |
| 2020 Q4 | 5.84 Billion USD | -5.04% |
| 2019 Q4 | 4.69 Billion USD | 2.89% |
| 2019 FY | 4.69 Billion USD | 5.94% |
| 2019 Q1 | 4.43 Billion USD | 0.19% |
| 2019 Q2 | 4.39 Billion USD | -0.95% |
| 2019 Q3 | 4.55 Billion USD | 3.75% |
| 2018 Q3 | 4.69 Billion USD | 1.53% |
| 2018 Q1 | 4.59 Billion USD | -0.79% |
| 2018 FY | 4.42 Billion USD | -4.45% |
| 2018 Q2 | 4.62 Billion USD | 0.61% |
| 2018 Q4 | 4.42 Billion USD | -5.71% |
| 2017 Q4 | 4.63 Billion USD | 1.14% |
| 2017 Q3 | 4.58 Billion USD | 13.95% |
| 2017 Q2 | 4.01 Billion USD | 2.07% |
| 2017 Q1 | 3.93 Billion USD | -2.11% |
| 2017 FY | 4.63 Billion USD | 15.15% |
| 2016 Q1 | 3.66 Billion USD | -1.67% |
| 2016 Q4 | 4.02 Billion USD | 4.72% |
| 2016 Q2 | 3.08 Billion USD | -15.81% |
| 2016 FY | 4.02 Billion USD | 7.89% |
| 2016 Q3 | 3.84 Billion USD | 24.45% |
| 2015 Q1 | 3.65 Billion USD | 46.91% |
| 2015 FY | 3.72 Billion USD | 49.75% |
| 2015 Q4 | 3.72 Billion USD | 2.88% |
| 2015 Q2 | 3.64 Billion USD | -0.27% |
| 2015 Q3 | 3.62 Billion USD | -0.65% |
| 2014 Q4 | 2.49 Billion USD | 2.05% |
| 2014 Q2 | 2.34 Billion USD | 0.21% |
| 2014 FY | 2.49 Billion USD | 10.73% |
| 2014 Q1 | 2.34 Billion USD | 4.07% |
| 2014 Q3 | 2.44 Billion USD | 4.04% |
| 2013 Q2 | 1.6 Billion USD | 0.2% |
| 2013 Q1 | 1.59 Billion USD | -0.21% |
| 2013 FY | 2.24 Billion USD | 40.43% |
| 2013 Q3 | 1.62 Billion USD | 1.19% |
| 2013 Q4 | 2.24 Billion USD | 38.8% |
| 2012 Q1 | 1.29 Billion USD | -0.51% |
| 2012 FY | 1.6 Billion USD | 22.86% |
| 2012 Q4 | 1.6 Billion USD | 2.19% |
| 2012 Q3 | 1.56 Billion USD | 2.27% |
| 2012 Q2 | 1.53 Billion USD | 18.15% |
| 2011 FY | 1.3 Billion USD | 3.25% |
| 2011 Q4 | 1.3 Billion USD | 0.66% |
| 2011 Q3 | 1.29 Billion USD | 1.15% |
| 2011 Q1 | 1.26 Billion USD | 0.12% |
| 2011 Q2 | 1.28 Billion USD | 1.29% |
| 2010 Q1 | 966.2 Million USD | 5.35% |
| 2010 FY | 1.26 Billion USD | 37.67% |
| 2010 Q2 | 985.51 Million USD | 2.0% |
| 2010 Q3 | 1.24 Billion USD | 26.28% |
| 2010 Q4 | 1.26 Billion USD | 1.45% |
| 2009 Q3 | 869.35 Million USD | 2.95% |
| 2009 FY | 917.16 Million USD | 1.15% |
| 2009 Q1 | 900.28 Million USD | -0.71% |
| 2009 Q2 | 844.43 Million USD | -6.2% |
| 2009 Q4 | 917.16 Million USD | 5.5% |
| 2008 Q3 | 859.03 Million USD | 0.52% |
| 2008 FY | 906.69 Million USD | 11.21% |
| 2008 Q1 | 827.7 Million USD | 1.52% |
| 2008 Q2 | 854.55 Million USD | 3.24% |
| 2008 Q4 | 906.69 Million USD | 5.55% |
| 2007 Q2 | 781.63 Million USD | 73.79% |
| 2007 Q3 | 791.05 Million USD | 1.2% |
| 2007 Q1 | 449.76 Million USD | -2.95% |
| 2007 Q4 | 815.27 Million USD | 3.06% |
| 2007 FY | 815.27 Million USD | 75.92% |
| 2006 FY | 463.43 Million USD | 137.29% |
| 2006 Q3 | 467.07 Million USD | -0.35% |
| 2006 Q2 | 468.71 Million USD | -4.0% |
| 2006 Q1 | 488.22 Million USD | 149.99% |
| 2006 Q4 | 463.43 Million USD | -0.78% |
| 2005 FY | 195.3 Million USD | -16.17% |
| 2005 Q4 | 195.3 Million USD | -6.48% |
| 2005 Q3 | 208.84 Million USD | 24.87% |
| 2005 Q2 | 167.24 Million USD | -7.56% |
| 2005 Q1 | 180.93 Million USD | -22.34% |
| 2004 Q1 | 239.29 Million USD | -6.65% |
| 2004 FY | 232.96 Million USD | -9.12% |
| 2004 Q4 | 232.96 Million USD | -25.39% |
| 2004 Q3 | 312.23 Million USD | -10.13% |
| 2004 Q2 | 347.41 Million USD | 45.18% |
| 2003 Q3 | 284.44 Million USD | -7.16% |
| 2003 Q2 | 306.38 Million USD | 67.32% |
| 2003 Q1 | 183.11 Million USD | 65.54% |
| 2003 FY | 256.34 Million USD | 131.74% |
| 2003 Q4 | 256.34 Million USD | -9.88% |
| 2002 Q1 | 157.3 Million USD | -8.44% |
| 2002 Q4 | 110.61 Million USD | -13.22% |
| 2002 FY | 110.61 Million USD | -35.62% |
| 2002 Q2 | 141.97 Million USD | -9.75% |
| 2002 Q3 | 127.46 Million USD | -10.22% |
| 2001 Q1 | 65.44 Million USD | -14.94% |
| 2001 Q2 | 98.32 Million USD | 50.24% |
| 2001 Q3 | 90.4 Million USD | -8.05% |
| 2001 Q4 | 171.81 Million USD | 90.05% |
| 2001 FY | 171.81 Million USD | 123.33% |
| 2000 Q1 | 94.49 Million USD | -8.75% |
| 2000 FY | 76.93 Million USD | -25.7% |
| 2000 Q4 | 76.93 Million USD | -7.67% |
| 2000 Q3 | 83.32 Million USD | -3.21% |
| 2000 Q2 | 86.09 Million USD | -8.89% |
| 1999 Q2 | 51.4 Million USD | 91.79% |
| 1999 Q4 | 103.54 Million USD | -7.96% |
| 1999 FY | 103.54 Million USD | 228.73% |
| 1999 Q3 | 112.5 Million USD | 118.87% |
| 1999 Q1 | 26.8 Million USD | 0.0% |
| 1998 FY | 31.5 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -359.756% |
| Alkermes plc | 2.13 Billion USD | -220.266% |
| Agenus Inc. | 313.91 Million USD | -2079.458% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -78.638% |
| Aptorum Group Limited | 20.64 Million USD | -33047.155% |
| Ardelyx, Inc. | 297.57 Million USD | -2199.088% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -793.682% |
| Bicycle Therapeutics plc | 595.34 Million USD | -1049.185% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -9182.792% |
| ChromaDex Corporation | 54.96 Million USD | -12347.426% |
| Chimerix, Inc. | 212.77 Million USD | -3115.432% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -24098.882% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -1451.496% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -206.857% |
| Precision BioSciences, Inc. | 159.78 Million USD | -4181.863% |
| Dyadic International, Inc. | 8.21 Million USD | -83138.917% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -21455.145% |
| Fortress Biotech, Inc. | 167.52 Million USD | -3983.905% |
| Lantern Pharma Inc. | 43.64 Million USD | -15574.632% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -4140.567% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -47061.849% |
| Incyte Corporation | 6.78 Billion USD | -0.877% |
| IO Biotech, Inc. | 150.71 Million USD | -4439.34% |
| Jaguar Health, Inc. | 50.76 Million USD | -13377.539% |
| Novavax, Inc. | 1.85 Billion USD | -268.752% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -1698.496% |
| Opthea Limited | 188.79 Million USD | -3523.899% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -721.258% |
| ContextLogic Inc. | 423 Million USD | -1517.4% |
| MiMedx Group, Inc. | 239.04 Million USD | -2762.033% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -3838.157% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -132240.4% |
| NextCure, Inc. | 129.41 Million USD | -5186.439% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -12581.847% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -18527.251% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -21080.778% |
| Vaxcyte, Inc. | 1.4 Billion USD | -385.938% |
| PDS Biotechnology Corporation | 59.39 Million USD | -11419.774% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -968.088% |
| Pharming Group N.V. | 462.85 Million USD | -1378.134% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -17587.702% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -988.465% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -36053.67% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -36053.67% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -4038.4% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -15007.212% |
| Acelyrin, Inc. | 742.69 Million USD | -821.192% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -103772.757% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -106749.961% |
| Summit Therapeutics Inc. | 202.94 Million USD | -3271.095% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -9098.918% |
| Senti Biosciences, Inc. | 119.48 Million USD | -5625.957% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -2896.209% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -3968.169% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -82698.052% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -143216.621% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -1358.167% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -5432.905% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -2388.317% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -1346.917% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -67605.126% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -3089.469% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -604197.011% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -1553.192% |
| Immix Biopharma, Inc. | 19.92 Million USD | -34236.502% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -1748.957% |
| MEI Pharma, Inc. | 41.37 Million USD | -16435.596% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -21012.149% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -1907.524% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -5736.3% |
| Fortress Biotech, Inc. | 167.52 Million USD | -3983.905% |
| Precigen, Inc. | 151.04 Million USD | -4429.573% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -20011.714% |
| AlloVir, Inc. | 190.79 Million USD | -3485.821% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -1717.395% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -1251.516% |
| ImmuCell Corporation | 43.8 Million USD | -15517.209% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -953.663% |
| Onconetix, Inc. | 88.82 Million USD | -7602.647% |
| PureTech Health plc | 693.97 Million USD | -885.86% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -6903.74% |
| Elevation Oncology, Inc. | 89.09 Million USD | -7579.342% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -110212.851% |
| Seer, Inc. | 436.26 Million USD | -1468.207% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -8284.626% |
| Innoviva, Inc. | 1.24 Billion USD | -450.186% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -5066.476% |
| ESSA Pharma Inc. | 149.12 Million USD | -4487.919% |
| GlycoMimetics, Inc. | 45.31 Million USD | -14997.386% |
| GT Biopharma, Inc. | 14.1 Million USD | -48391.055% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -2122.072% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -2730.583% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -1349.778% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -13395.085% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -7085.652% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -1083138.282% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -1108.036% |
| Aptose Biosciences Inc. | 12.92 Million USD | -52843.159% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -30837.484% |
| Soligenix, Inc. | 9.79 Million USD | -69731.329% |
| Century Therapeutics, Inc. | 360.69 Million USD | -1796.804% |
| Kura Oncology, Inc. | 448.93 Million USD | -1423.963% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -2413.918% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -39458.271% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -6068.534% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -3234.911% |
| Autolus Therapeutics plc | 375.38 Million USD | -1722.576% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -2618.849% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -1826.214% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -13824.943% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -934.828% |
| GRI Bio, Inc. | 2.95 Million USD | -231348.004% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -64411.619% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -3912.317% |
| IGM Biosciences, Inc. | 423.41 Million USD | -1515.83% |
| INmune Bio, Inc. | 57 Million USD | -11902.602% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -2974.795% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -8050.466% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -26096.118% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -99295.746% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -8994.732% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -4545.998% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -4033.799% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -986.652% |
| Verastem, Inc. | 149.71 Million USD | -4469.66% |
| Abeona Therapeutics Inc. | 64 Million USD | -10589.671% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -1235.849% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -4329.455% |
| Histogen Inc. | 19.07 Million USD | -35770.618% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -30105.521% |
| Surrozen, Inc. | 46.08 Million USD | -14747.229% |
| Organovo Holdings, Inc. | 6.34 Million USD | -107658.749% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -158688.73% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -4650.23% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -57869.861% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -8989.657% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -80207.574% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -1784.9% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -37710.616% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -1493.286% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -54147.977% |
| Apollomics, Inc. | 55.38 Million USD | -12252.362% |
| Amarin Corporation plc | 831.68 Million USD | -722.62% |
| Mesoblast Limited | 669.15 Million USD | -922.427% |
| Turnstone Biologics Corp. | 112.81 Million USD | -5964.444% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -1088.275% |
| Synaptogenix, Inc. | 31.11 Million USD | -21889.06% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -56052.356% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -1148.326% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -116407.134% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -93044.383% |
| Exelixis, Inc. | 2.94 Billion USD | -132.521% |
| Better Therapeutics, Inc. | 22.94 Million USD | -29720.002% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -1776.782% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -767.42% |
| NLS Pharmaceutics AG | 1.84 Million USD | -370389.066% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -85649.052% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -46457.353% |
| Gritstone bio, Inc. | 177.76 Million USD | -3748.592% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -7072.995% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -38201.98% |
| Avid Bioservices, Inc. | 336.55 Million USD | -1932.821% |
| Insmed Incorporated | 1.32 Billion USD | -414.469% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -70956.895% |
| MediWound Ltd. | 66.45 Million USD | -10194.472% |
| OmniAb, Inc. | 401.98 Million USD | -1601.955% |
| Alector, Inc. | 621.82 Million USD | -1000.242% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -1807.865% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -127114.634% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -11968.022% |
| Zai Lab Limited | 1.03 Billion USD | -560.198% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -1329.94% |
| Aura Biosciences, Inc. | 255.07 Million USD | -2582.193% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -812.178% |
| Immunic, Inc. | 54.29 Million USD | -12499.869% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -2469.867% |
| Veracyte, Inc. | 1.13 Billion USD | -501.29% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -57767.962% |
| FibroGen, Inc. | 423.52 Million USD | -1515.38% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -194651.011% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -144341.071% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -125908.486% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 39.951% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -77601.34% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -1222.166% |
| TG Therapeutics, Inc. | 329.58 Million USD | -1975.811% |
| Galecto, Inc. | 38.22 Million USD | -17797.306% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -23758.289% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -57.018% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -2806.324% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -27440.468% |
| XBiotech Inc. | 227.24 Million USD | -2910.699% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -7072.995% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -4697.758% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -2292.872% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -5250.478% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -1691.0% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -358.856% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -1775.224% |
| Vaxxinity, Inc. | 44.35 Million USD | -15325.344% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -1223.43% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -36664.368% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -2142.781% |
| NexImmune, Inc. | 8.59 Million USD | -79509.537% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -63749.572% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -39845.389% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 79.318% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -30786.021% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -1744027.822% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -3847.177% |
| Ainos, Inc. | 31.84 Million USD | -21386.229% |
| Pluri Inc. | 39.52 Million USD | -17208.683% |
| Prothena Corporation plc | 696.38 Million USD | -882.45% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -2320.812% |
| Celularity Inc. | 143.88 Million USD | -4654.778% |
| Rallybio Corporation | 115.62 Million USD | -5817.318% |
| Cue Biopharma, Inc. | 61.53 Million USD | -11019.134% |
| MeiraGTx Holdings plc | 458.16 Million USD | -1393.252% |
| Omeros Corporation | 378.26 Million USD | -1708.661% |
| Humacyte, Inc. | 128.22 Million USD | -5235.707% |
| Immunocore Holdings plc | 597 Million USD | -1045.995% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -21786.826% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -9883.369% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -552.047% |
| CalciMedica, Inc. | 12.18 Million USD | -56047.747% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -2597.261% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -3903.091% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -2099.625% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -1110.263% |
| Pulmatrix, Inc. | 33.95 Million USD | -20047.25% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -25102.988% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -4757.092% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -425.882% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -5155.13% |
| Cytokinetics, Incorporated | 824.31 Million USD | -729.973% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -32289.353% |
| Nutriband Inc. | 7.51 Million USD | -90913.208% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -8565.303% |
| Vor Biopharma Inc. | 209.82 Million USD | -3160.577% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 5.274% |
| Evogene Ltd. | 51.1 Million USD | -13288.394% |
| ProKidney Corp. | 420.55 Million USD | -1526.815% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -12377.163% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -71763.479% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -1152.169% |
| CorMedix Inc. | 82.05 Million USD | -8237.322% |
| BioLineRx Ltd. | 63.92 Million USD | -10602.547% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -1599.494% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -24161.004% |
| Atai Life Sciences N.V. | 293.47 Million USD | -2231.215% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -4093.972% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -5269.416% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -1117.309% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -6973.691% |
| MediciNova, Inc. | 66.26 Million USD | -10223.835% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -7679.146% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -153217.871% |
| GeoVax Labs, Inc. | 9.28 Million USD | -73598.606% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -1063.071% |
| Biomea Fusion, Inc. | 199.92 Million USD | -3322.051% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -259.483% |
| Mereo BioPharma Group plc | 66.49 Million USD | -10188.28% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -1310.361% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -1016.304% |
| Absci Corporation | 234.48 Million USD | -2817.777% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -93428.407% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -1912.881% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -4044.366% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -1199.889% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -2363.729% |
| Allakos Inc. | 243.61 Million USD | -2708.425% |
| Imunon, Inc. | 21.91 Million USD | -31114.442% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -2554.933% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -1000.791% |
| BioAtla, Inc. | 119.65 Million USD | -5617.631% |
| NLS Pharmaceutics AG | 1.84 Million USD | -370389.066% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -212372.143% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -964.283% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -7031.498% |
| XOMA Corporation | 234.3 Million USD | -2820.006% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -2992.46% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -5336.575% |
| aTyr Pharma, Inc. | 122.06 Million USD | -5504.793% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -4345.399% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -1079.036% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -1295.038% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -6093.233% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -45036.575% |
| Akari Therapeutics, Plc | 4.35 Million USD | -156997.658% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -40056.537% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -294.722% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -221742.868% |
| UroGen Pharma Ltd. | 178.31 Million USD | -3736.893% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -1353.384% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -1231035.204% |
| Orgenesis Inc. | 14.55 Million USD | -46914.864% |
| Entera Bio Ltd. | 11.76 Million USD | -58052.172% |
| GH Research PLC | 226.3 Million USD | -2923.245% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -12408.873% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -6268.073% |
| Xencor, Inc. | 952.69 Million USD | -618.134% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -87795.738% |
| Replimune Group, Inc. | 487.72 Million USD | -1302.767% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -84666.789% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -955.087% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -221742.868% |
| Portage Biotech Inc. | 7.77 Million USD | -87849.646% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -153217.871% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -2370.383% |
| OncoCyte Corporation | 74.89 Million USD | -9035.292% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -336386.4% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -118130.95% |
| Purple Biotech Ltd. | 44.3 Million USD | -15343.102% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -19948.066% |
| scPharmaceuticals Inc. | 94.47 Million USD | -7141.401% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -37814.209% |
| HilleVax, Inc. | 344.43 Million USD | -1886.332% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -215315.712% |
| Tharimmune, Inc. | 10.94 Million USD | -62400.981% |
| Genprex, Inc. | 10.67 Million USD | -64016.433% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -1278.813% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -7008.011% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -281911.665% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -164146.787% |
| OKYO Pharma Limited | 1.54 Million USD | -443795.595% |
| Savara Inc. | 177.56 Million USD | -3753.035% |
| Curis, Inc. | 77.28 Million USD | -8752.777% |
| Daré Bioscience, Inc. | 21.28 Million USD | -32047.044% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -10598.563% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -84510.475% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -35218.791% |
| BeiGene, Ltd. | 5.8 Billion USD | -17.851% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -56121.571% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -227.57% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -1811.324% |
| Erasca, Inc. | 395.29 Million USD | -1630.75% |
| bluebird bio, Inc. | 619.16 Million USD | -1004.98% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -158147.029% |
| DBV Technologies S.A. | 182.98 Million USD | -3638.867% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -158147.029% |
| Moderna, Inc. | 18.42 Billion USD | 62.87% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -37456.145% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -58950.604% |
| Molecular Templates, Inc. | 35.38 Million USD | -19235.848% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -4848.181% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -767.219% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -2152.343% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -6481.882% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -1369.331% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -2082.768% |
| MacroGenics, Inc. | 306.82 Million USD | -2129.843% |
| RenovoRx, Inc. | 1.46 Million USD | -466585.061% |
| Adicet Bio, Inc. | 207.29 Million USD | -3200.419% |
| Prime Medicine, Inc. | 193.85 Million USD | -3429.31% |
| Aditxt, Inc. | 44.57 Million USD | -15247.375% |
| Adagene Inc. | 115.72 Million USD | -5811.753% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -153499.297% |
| Quantum-Si incorporated | 298.25 Million USD | -2193.916% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -359.955% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -88646.839% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -1847.615% |
| SciSparc Ltd. | 11.18 Million USD | -61084.073% |
| Vericel Corporation | 353.65 Million USD | -1834.531% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -55920.814% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -11923.778% |
| Generation Bio Co. | 374.75 Million USD | -1725.606% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -2586.5% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -4214.645% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -1904.19% |
| Invivyd, Inc. | 229.18 Million USD | -2885.24% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -710.636% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -56120.181% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -3651.084% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -33397.86% |
| 2seventy bio, Inc. | 565.42 Million USD | -1109.991% |
| ADMA Biologics, Inc. | 329.18 Million USD | -1978.365% |
| Clene Inc. | 52.34 Million USD | -12971.212% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -11548.389% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -5167.066% |
| GeoVax Labs, Inc. | 9.28 Million USD | -73598.606% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -946.598% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -6503.153% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -5147.191% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -6913.285% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -9536.468% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -2720.663% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -249.045% |
| Evaxion Biotech A/S | 12.88 Million USD | -52982.514% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -2614.276% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -808.956% |
| Trevena, Inc. | 40.6 Million USD | -16749.164% |
| Surrozen, Inc. | 46.08 Million USD | -14747.229% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -2929.175% |
| Cingulate Inc. | 3.49 Million USD | -195853.842% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -41042.6% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -10314.984% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -58452.173% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -2447.922% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -813.485% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -5334.502% |
| Clearmind Medicine Inc. | 4.32 Million USD | -158109.703% |
| Kronos Bio, Inc. | 213.27 Million USD | -3107.818% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -4181.782% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -79819.573% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -1756.659% |
| Statera Biopharma, Inc. | 21.16 Million USD | -32217.925% |
| ImmunityBio, Inc. | 504.45 Million USD | -1256.245% |
| Korro Bio, Inc. | 221.66 Million USD | -2986.488% |
| Kineta, Inc. | 10.28 Million USD | -66446.085% |
| BioVie Inc. | 25.2 Million USD | -27040.231% |
| Codexis, Inc. | 136.56 Million USD | -4909.925% |
| Celularity Inc. | 143.88 Million USD | -4654.778% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -976.819% |
| Celcuity Inc. | 191.21 Million USD | -3477.881% |
| Virax Biolabs Group Limited | 5.48 Million USD | -124656.413% |
| Cibus, Inc. | 544.41 Million USD | -1156.698% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -5334.415% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -33202.195% |
| IN8bio, Inc. | 33.7 Million USD | -20196.072% |
| Kodiak Sciences Inc. | 479.37 Million USD | -1327.201% |
| Annexon, Inc. | 297.67 Million USD | -2198.354% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -3854.455% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -4876.833% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -32489.925% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -128.811% |
| Eyenovia, Inc. | 28.77 Million USD | -23672.591% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -2867.797% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -94606.575% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -11129.365% |
| Arcellx, Inc. | 825.13 Million USD | -729.153% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -8280.517% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -1379.986% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -22149.115% |
| Moolec Science SA | 24.05 Million USD | -28345.889% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -2106.079% |
| Geron Corporation | 394.07 Million USD | -1636.113% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -6626.579% |
| Royalty Pharma plc | 16.38 Billion USD | 58.237% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -1049.911% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -97709.635% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -56783.872% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -2926.454% |
| Humacyte, Inc. | 128.22 Million USD | -5235.707% |
| Structure Therapeutics Inc. | 482.01 Million USD | -1319.369% |
| 89bio, Inc. | 596.26 Million USD | -1047.402% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -2613.285% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -369716.378% |
| Genelux Corporation | 27.89 Million USD | -24428.029% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -7552.543% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -2882.013% |
| Notable Labs, Ltd. | 19.54 Million USD | -34911.53% |
| Liquidia Corporation | 120.43 Million USD | -5580.932% |
| Mustang Bio, Inc. | 17.74 Million USD | -38461.622% |
| Immunovant, Inc. | 666.71 Million USD | -926.171% |
| Quantum-Si incorporated | 298.25 Million USD | -2193.916% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -4637.919% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -12532.206% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -3797.328% |
| Acasti Pharma Inc. | 73.3 Million USD | -9233.701% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -150189.558% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -26096.118% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -609.123% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -131724.877% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -29932.057% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -13158.15% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -3686.355% |
| PepGen Inc. | 143.05 Million USD | -4682.599% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -17801.989% |
| United Therapeutics Corporation | 7.16 Billion USD | 4.54% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -35561.209% |
| Solid Biosciences Inc. | 164.93 Million USD | -4047.96% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -116407.134% |
| Immuneering Corporation | 102.58 Million USD | -6569.234% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -158688.73% |
| Silo Pharma, Inc. | 7.74 Million USD | -88222.727% |
| Belite Bio, Inc | 94.64 Million USD | -7128.929% |
| XOMA Corporation | 234.3 Million USD | -2820.006% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -2833.943% |
| Bionomics Limited | 27.64 Million USD | -24644.403% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -1604.418% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -6270.919% |
| uniQure N.V. | 831.68 Million USD | -722.616% |
| Cassava Sciences, Inc. | 151.66 Million USD | -4411.056% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -153499.297% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -2397.984% |
| Forte Biosciences, Inc. | 38.98 Million USD | -17451.573% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -167869.838% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -18475.665% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -94606.575% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -194651.011% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -57776.686% |
| Altimmune, Inc. | 210.64 Million USD | -3148.008% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -779.519% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -6270.919% |
| Compugen Ltd. | 121.33 Million USD | -5538.653% |
| Peak Bio, Inc. | 2.59 Million USD | -263401.906% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -3870.128% |
| Benitec Biopharma Inc. | 52.21 Million USD | -13004.009% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -1901.294% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -19575.044% |
| Zura Bio Limited | 100.84 Million USD | -6684.41% |
| PolyPid Ltd. | 15.37 Million USD | -44406.915% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -5635.462% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -19575.044% |
| Instil Bio, Inc. | 325.63 Million USD | -2001.036% |
| argenx SE | 4.54 Billion USD | -50.615% |
| Immunome, Inc. | 148.54 Million USD | -4505.899% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -4261.181% |
| Verona Pharma plc | 308.12 Million USD | -2120.406% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -7767.619% |
| Shattuck Labs, Inc. | 159.56 Million USD | -4187.686% |
| CervoMed Inc. | 9.97 Million USD | -68504.548% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -3530.345% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -59977.301% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -3713.496% |
| Moolec Science SA | 24.05 Million USD | -28345.889% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -111736.949% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -3855.955% |
| AnaptysBio, Inc. | 452.38 Million USD | -1412.327% |
| Design Therapeutics, Inc. | 289.64 Million USD | -2262.081% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -9294.58% |
| NeurAxis, Inc. | 509.49 Thousand USD | -1342712.533% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -126175.434% |
| Lumos Pharma, Inc. | 40.63 Million USD | -16735.482% |
| Achilles Therapeutics plc | 161.45 Million USD | -4137.441% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -7767.619% |
| 180 Life Sciences Corp. | 5.25 Million USD | -129981.457% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -9614.35% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -79819.573% |
| Nutriband Inc. | 7.51 Million USD | -90913.208% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -2586.289% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -3332.799% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -8877.068% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -11712.976% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -1199.351% |
| Palisade Bio, Inc. | 14.05 Million USD | -48587.753% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -3153.336% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -368.695% |
| Neurogene Inc. | 222.57 Million USD | -2973.869% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -958.055% |
| AEON Biopharma, Inc. | 6.84 Million USD | -99850.373% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -1410.168% |
| Sesen Bio, Inc. | 189.17 Million USD | -3516.566% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -2416.526% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -49795.477% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -776.734% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -2462.456% |
| Athira Pharma, Inc. | 160.24 Million USD | -4169.464% |
| Vaccinex, Inc. | 3.63 Million USD | -188322.005% |
| HCW Biologics Inc. | 28.51 Million USD | -23894.124% |
| XOMA Corporation | 234.3 Million USD | -2820.006% |
| Nektar Therapeutics | 398.03 Million USD | -1618.853% |
| Arvinas, Inc. | 1.3 Billion USD | -424.422% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -40056.537% |
| Merus N.V. | 458.49 Million USD | -1392.19% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -3247.721% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -3696.588% |
| Rezolute, Inc. | 132.73 Million USD | -5054.255% |
| Clene Inc. | 52.34 Million USD | -12971.212% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -45743.332% |
| BeyondSpring Inc. | 24.8 Million USD | -27478.213% |
| Synlogic, Inc. | 75.55 Million USD | -8955.729% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -57576.64% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -72962.826% |
| Peak Bio, Inc. | 2.59 Million USD | -263401.906% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -3813.222% |
| Krystal Biotech, Inc. | 818.35 Million USD | -736.019% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -2745.475% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -842.645% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -191157.205% |
| MannKind Corporation | 475.19 Million USD | -1339.737% |
| Ikena Oncology, Inc. | 192.09 Million USD | -3461.628% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -51055.997% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -5770.655% |
| Gossamer Bio, Inc. | 311.91 Million USD | -2093.412% |
| CohBar, Inc. | 16.36 Million USD | -41704.608% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -19356.824% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -93428.407% |
| Legend Biotech Corporation | 1.84 Billion USD | -270.095% |
| Mural Oncology plc | 301.74 Million USD | -2167.346% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -21817.677% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -120342.169% |
| Disc Medicine, Inc. | 367.99 Million USD | -1759.151% |
| Champions Oncology, Inc. | 26.13 Million USD | -26080.939% |
| REGENXBIO Inc. | 573.97 Million USD | -1091.979% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -252536.199% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -4331.492% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -56556.517% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -1912.029% |
| Vaxart, Inc. | 91.83 Million USD | -7350.292% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -11320.967% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -4512.516% |
| Cellectis S.A. | 334.27 Million USD | -1946.73% |
| Longeveron Inc. | 12.17 Million USD | -56080.021% |
| Repare Therapeutics Inc. | 253.9 Million USD | -2594.595% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -109.571% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -3306.375% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -227.57% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -420921.723% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -2363.569% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -4094.78% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -4831.098% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -26706.688% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 69.901% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -492.903% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -55920.814% |
| Veru Inc. | 50.59 Million USD | -13422.044% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -14918.995% |
| Cingulate Inc. | 3.49 Million USD | -195853.842% |
| Passage Bio, Inc. | 150.54 Million USD | -4444.557% |
| Context Therapeutics Inc. | 16.06 Million USD | -42493.014% |
| Exicure, Inc. | 11.58 Million USD | -58981.2% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -1719.343% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -4132.565% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -39057.526% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -1956.11% |
| Nuvalent, Inc. | 732.38 Million USD | -834.155% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -45681.363% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -7539.64% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -48110.859% |
| OmniAb, Inc. | 401.98 Million USD | -1601.955% |
| Anew Medical, Inc. | 19.45 Million USD | -35064.574% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -25498.522% |
| Lipocine Inc. | 23 Million USD | -29644.714% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -4793.605% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -2139.001% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -8050.466% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -5529.096% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -86120.58% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -675.448% |
| Ocugen, Inc. | 64.54 Million USD | -10499.413% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -5393.454% |
| Q32 Bio Inc. | 306.11 Million USD | -2134.949% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -162485.623% |
| Alumis Inc. Common Stock | 89.61 Million USD | -7534.695% |
| Equillium, Inc. | 50.53 Million USD | -13439.685% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -8998.481% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -16476.251% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -402145.403% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -26071.925% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -10516.848% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -183463.069% |
| Dominari Holdings Inc. | 57.55 Million USD | -11786.45% |
| Edesa Biotech, Inc. | 8.89 Million USD | -76854.631% |
| vTv Therapeutics Inc. | 11.01 Million USD | -61994.781% |
| Bio-Techne Corporation | 2.81 Billion USD | -143.197% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -630.068% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -743.135% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -2363.977% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -16305.935% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -924.824% |
| Nkarta, Inc. | 378.88 Million USD | -1705.72% |
| BioCardia, Inc. | 2.98 Million USD | -228945.966% |
| Iterum Therapeutics plc | 26.25 Million USD | -25954.317% |